Pfizer Diflucan Partnership
Pfizer created the Diflucan Partnership in 2000 to provide treatment for two AIDS-related fungal infections in developing countries. Since the program's inception, Pfizer has over provided USD 1.1 billion of products and its program partners distribute millions of Diflucan (fluconazole) treatments free of charge to governments and NGOs in 63 developing countries in Africa, Asia, the Caribbean and Latin America. Pfizer has also provided training and education materials to 20,000 healthcare professionals. Pfizer's partners provide technical assistance, support program management and distribute Diflucan to participating governments and organizations. These partners include Axois International, IMA World Health and International Dispensary Association. The Diflucan Partnership involves the following activities: Donating Diflucan to governments and organizations to treat patients; Distributing materials to train healthcare workers in the diagnosis and treatment of AIDS-related infections; Providing inventory management training tools for pharmacists to improve medicine handling and distribution; Sharing best practices for effective medicine distribution and supporting industry collaboration on access to medicines.